Therefore, we hypothesized that induced expression of HIF-2 upon cetuximab and radiation therapy could functionally compensate the inhibition of HIF-1, and participate to the resistance of HNSCC cells to EGFR blockade. This evidence concerns the gene HIF1A and head and neck squamous cell carcinoma.